المؤلفون: Hendriks, L. E., Kerr, K. M., Menis, J., Mok, T. S., Nestle, U., Passaro, A., Planchard, D., Peters, S., Smit, E. F., Solomon, B. J., Veronesi, G., Reck, M., Guidelines Committee, ESMO

المصدر: Hendriks , L E , Kerr , K M , Menis , J , Mok , T S , Nestle , U , Passaro , A , Planchard , D , Peters , S , Smit , E F , Solomon , B J , Veronesi , G , Reck , M , ESMO Guidelines Committee & Guidelines Committee , ESMO 2023 , ' Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ' , Annals of Oncology , vol. 34 , no. 4 , pp. 358-376 . https://doi.org/10.1016/j.annonc.2022.12.013Test

مصطلحات موضوعية: ESCAT, ESMO Clinical Practice Guideline (CPG), ESMO-MCBS, non-oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC), treatment, targeted therapy, immunotherapy, RANDOMIZED PHASE-III, QUALITY-OF-LIFE, PACLITAXEL DOUBLET CHEMOTHERAPY, RESPONSE EVALUATION CRITERIA, PLATINUM-BASED CHEMOTHERAPY, PEMETREXED PLUS CISPLATIN, SPECIFIED FINAL ANALYSIS, INDIVIDUAL PATIENT DATA, ELDERLY-PATIENTS, 2ND-LINE TREATMENT

وصف الملف: application/pdf

العلاقة: https://cris.maastrichtuniversity.nl/en/publications/7f71c7db-b119-4345-a38e-5b383cefe585Test

الإتاحة: https://doi.org/10.1016/j.annonc.2022.12.013Test
https://cris.maastrichtuniversity.nl/en/publications/7f71c7db-b119-4345-a38e-5b383cefe585Test
https://cris.maastrichtuniversity.nl/ws/files/192165470/Hendriks-2023-Non-oncogene-addicted-metastatic-non.pdfTest

المؤلفون: L.E. Hendriks, K.M. Kerr, J. Menis, T.S. Mok, U. Nestle, A. Passaro, S. Peters, D. Planchard, E.F. Smit, B.J. Solomon, G. Veronesi, M. Reck

المصدر: Annals of Oncology. 34:358-376

مصطلحات موضوعية: PLATINUM-BASED CHEMOTHERAPY, treatment, INDIVIDUAL PATIENT DATA, ESMO-MCBS, Hematology, RANDOMIZED PHASE-III, targeted therapy, PACLITAXEL DOUBLET CHEMOTHERAPY, RESPONSE EVALUATION CRITERIA, PEMETREXED PLUS CISPLATIN, ESMO Clinical Practice Guideline (CPG), Oncology, QUALITY-OF-LIFE, SPECIFIED FINAL ANALYSIS, immunotherapy, non-oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC), ELDERLY-PATIENTS, ESCAT, 2ND-LINE TREATMENT

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3ec5ec6e6a8cfc90da92fc3ccf8c322Test
https://doi.org/10.1016/j.annonc.2022.12.013Test